Brimonidine Tartrate Solution/ Drops
Product Images NDC 70069-232

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 70069-232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure 1 (Fd76c55c Cb68 4884 8a1a A4c6bf66562a 01)

Chemical structure of brimonidine tartrate showing the molecular arrangement of brimonidine and the tartrate component.*

FDA Label Image

5 mL Bottle Label (Fd76c55c Cb68 4884 8a1a A4c6bf66562a 02)

Label for Brimonidine Tartrate Ophthalmic Solution 0.2%, a 5 mL eye drop solution. Contains Brimonidine tartrate 0.2% as the active ingredient and benzalkonium chloride 0.005% as a preservative. Manufactured for Somerset Therapeutics, LLC, Somerset, NJ. Storage instructions specify 15°-25°C (59°-77°F). The label includes a barcode and indicates the product is Rx only.*

FDA Label Image

5 mL Carton Label (Fd76c55c Cb68 4884 8a1a A4c6bf66562a 03)

Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.2%, a 5 mL ophthalmic drop solution. The label indicates it is Rx only with NDC 70069-231-01 and is manufactured for Somerset Therapeutics LLC. The label includes active ingredient information, preservative, inactives, usual dosage instructions, warnings, and storage conditions. Somerset Therapeutics LLC logo appears at the bottom.*

FDA Label Image

10 mL Container Label (Fd76c55c Cb68 4884 8a1a A4c6bf66562a 04)

Label for Brimonidine Tartrate Ophthalmic Solution 0.2%, an eye drop solution with a 10 mL volume. The label includes the active ingredient concentration (0.2%), preservative benzalkonium chloride (0.005%), storage instructions (store between 15°-25°C), and indicates it is for use in the eyes only. Manufactured for Somerset Therapeutics, LLC, Somerset, NJ, and made in India.*

FDA Label Image

10 mL Carton Label (Fd76c55c Cb68 4884 8a1a A4c6bf66562a 05)

Label for Brimonidine Tartrate Ophthalmic Solution 0.2%, 10 mL, a human prescription drug manufactured for Somerset Therapeutics, LLC. The label includes the NDC 70069-232-01, instructions to keep dropper tip uncontaminated, and storage conditions between 15°-25°C. It lists benzalkonium chloride as the preservative and various inactive ingredients, with a usage directive for eye drops. The packaging features the Somerset Therapeutics logo.*

FDA Label Image

15 mL Container Label (Fd76c55c Cb68 4884 8a1a A4c6bf66562a 06)

Label for Brimonidine Tartrate Ophthalmic Solution 0.2%, a 15 mL eye drop solution. Active ingredient is Brimonidine tartrate 0.2%, with benzalkonium chloride 0.005% as preservative. Manufactured for Somerset Therapeutics, LLC. The label includes storage instructions between 15°-25°C (59°-77°F) and features a barcode and NDC 70069-233-01.*

FDA Label Image

15 mL Carton Label (Fd76c55c Cb68 4884 8a1a A4c6bf66562a 07)

Label for Brimonidine Tartrate Ophthalmic Solution 0.2%, 15 mL, manufactured for Somerset Therapeutics, LLC. The label includes dosage strength, usage instructions, cautionary statements, inactive ingredients, and storage information. The product is for ophthalmic (eye) use only and is labeled Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.